Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 8, 2011, Pages 662-677

  Hossaini, Mehdi ^a   Cano, Sebastian Cardona ^a   Van Dis, Vera ^a   Haasdijk, Elize D ^a   Hoogenraad, Casper C ^b   Holstege, Jan C ^a   Jaarsma, Dick ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; GABA; Glycine; GlyT2; In situ hybridization; Interneurons; Spinal cord

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMATE DECARBOXYLASE; GLYCINE TRANSPORTER 2;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GLIA CELL; MOTONEURON; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD VENTRAL HORN;

ACTIVATING TRANSCRIPTION FACTOR 3; AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; GALECTIN 3; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; INTERNEURONS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION; NERVE DEGENERATION; NEUROGLIA; PARVALBUMINS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SPINAL CORD; SUPEROXIDE DISMUTASE; UBIQUITIN;

EID: 79961022340     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31822581ac     Document Type: Article

References (76)

1. Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: New insights into pathogenic mechanisms. Nature Rev 2009:10; 769-82
2. Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Cur Neurol Neurosci Rep 2006:6; 37-46 (Pubitemid 43154251)
3. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 2010:9; 995-1007
4. Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010:465; 223-26
5. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol 2008:7; 409-16
6. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006:314; 130-33 (Pubitemid 44547757)
7. Shaw BF, Valentine JS. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci 2007:32; 78-85 (Pubitemid 46199198)
8. Bergemalm D, Forsberg K, Srivastava V, et al. Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. J Neurochem 2010:114; 408-18
9. Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009:323; 1208-11
10. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009:323; 1205-8
11. Johnson BS, McCaffery JM, Lindquist S, et al. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2008:105; 6439-44 (Pubitemid 351758364)
12. Van Damme P, Robberecht W. Recent advances in motor neuron disease. Curr Opin Neurol 2009:22; 486-92
13. Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 2009:12; 627-36
14. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology 2009:73; 805-11
15. Piao YS, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003:13; 10-22 (Pubitemid 36133788)
16. Maekawa S, Al-Sarraj S, Kibble M, et al. Cortical selective vulnerability in motor neuron disease: A morphometric study. Brain 2004:127; 1237-51 (Pubitemid 38745505)
17. Stephens B, Guiloff RJ, Navarrete R, et al. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J Neurol Sci 2006:244; 41-58
18. Kikuchi H, Doh-ura K, Kawashima T, et al. Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule- associated protein 2 (MAP2) antibodies. Acta Neuropathol (Berl) 1999:97; 13-21 (Pubitemid 29132641)
19. Nishihira Y, Tan CF, Onodera O, et al. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 2008:116; 169-82
20. Geser F, Brandmeir NJ, Kwong LK, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008:65; 636-41 (Pubitemid 351679659)
21. Geser F, Stein B, Partain M, et al. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol 2011:121; 509-17
22. Kobayashi Z, Tsuchiya K, Arai T, et al. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss. J Neurol Sci 2010:298; 70-77
23. Attarian S, Vedel JP, Pouget J, et al. Progression of cortical and spinal dysfunctions over time in amyotrophic lateral sclerosis. Muscle Nerve 2008:37; 364-75 (Pubitemid 351304797)
24. Eisen A, Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 2001:24; 564-73 (Pubitemid 32246795)
25. Chou SM, Norris FH. Amyotrophic lateral sclerosis: Lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 1993:16; 864-69 (Pubitemid 23209146)
26. Brooks BR. The role of axonal transport in neurodegenerative disease spread: A meta-analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can J Neurol Sci 1991:18; 435-38
27. Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007:68; 1571-75 (Pubitemid 46717980)
28. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009:187; 761-72
29. Kato S, Takikawa M, Nakashima K, et al. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord 2000:1; 163-84
30. Beers DR, Henkel JS, Xiao Q, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006:103; 16021-26 (Pubitemid 44657585)
31. Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006:312; 1389-92 (Pubitemid 43839552)
32. Wang L, Sharma K, Grisotti G, et al. The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Neurobiol Dis 2009:35; 234-40
33. Yamanaka K, Chun SJ, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008:11; 251-53 (Pubitemid 351311795)
34. Jaarsma D, Teuling E, Haasdijk ED, et al. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 2008:28; 2075-88 (Pubitemid 351317636)
35. Jankowska E. Spinal interneuronal networks in the cat: Elementary components. Brain Res Rev 2008:57; 46-55 (Pubitemid 350213098)
36. Grillner S, Thomas MJ. Measured motion: Searching for simplicity in spinal locomotor networks. Curr Opin Neurobiol 2009:19; 572-86
37. Van Den Bosch L, Van Damme P, Bogaert E, et al. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006:1762;1068-82 (Pubitemid 44781176)
38. Oyanagi K, Ikuta F, Horikawa Y. Evidence for sequential degeneration of the neurons in the intermediate zone of the spinal cord in amyotrophic lateral sclerosis: A topographic and quantitative investigation. Acta Neuropathol 1989:77; 343-49 (Pubitemid 19070176)
39. Morrison BM, Janssen WG, Gordon JW, et al. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J Comp Neurol 1998:391; 64-77 (Pubitemid 28109620)
40. Martin LJ, Liu Z, Chen K, et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death. J Comp Neurol 2007:500; 20-46 (Pubitemid 44904300)
41. Chang Q, Martin LJ. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: A quantitative confocal analysis. Am J Pathol 2009:174; 574-85
42. Jiang M, Schuster JE, Fu R, et al. Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J Neurosci 2009:29; 15031-38
43. Pullen AH, Athanasiou D. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur J Neurosci 2009:29; 551-61
44. Gurney ME. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 1997:152; S67-S73 (Pubitemid 27505293)
45. Vlug AS, Teuling E, Haasdijk ED, et al. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun. phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur J Neurosci 2005:22; 1881-94 (Pubitemid 41579379)
46. Jaarsma D, Holstege JC, Troost D, et al. Induction of c-Jun. immunoreactivity in spinal cord and brainstem neurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neurosci Lett 1996:219; 179-82 (Pubitemid 26405562)
47. Zeilhofer HU, Studler B, Arabadzisz D, et al. Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J Comp Neurol 2005:482; 123-41 (Pubitemid 40066644)
48. Jaarsma D, Haasdijk E, Grashorn JAC, et al. Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial degeneration, axonal degeneration and premature motoneuron death, and accelerates the development of motoneuron disease in mice expressing fALS-mutant SOD1. Neurobiol Dis 2000:7; 623-43 (Pubitemid 32044287)
49. Hossaini M, French PJ, Holstege JC. Distribution of glycinergic neuronal somata in the rat spinal cord. Brain Res 2007:1142;61-69 (Pubitemid 46413199)
50. Speel EJ, Hopman AH, Komminoth P. Tyramide signal amplification for DNA and mRNA in situ hybridization. Methods Mol Biol 2006:326; 33-60
51. Hopman AH, Ramaekers FC, Speel EJ. Rapid synthesis of biotin-, digoxigenin-, trinitrophenyl-, and fluorochrome-labeled tyramides and their application for In situ hybridization using CARD amplification. J Histochem Cytochem 1998:46; 771-77 (Pubitemid 28272213)
52. Maatkamp A, Vlug A, Haasdijk E, et al. Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice. Eur J Neurosci 2004:20; 14-28 (Pubitemid 38932123)
53. Jaarsma D, Rognoni F, Van Duijn W, et al. CuZn superoxide dismutase (SOD1) accumulate in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis (ALS)-linked SOD1 mutations. Acta Neuropathol 2001:102; 293-305 (Pubitemid 32894698)
54. Zafra F, Aragon C, Olivares L, et al. Glycine transporters are differentially expressed among CNS cells. J Neurosci 1995:15; 3952-69
55. Mackie M, Hughes DI, Maxwell DJ, et al. Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 2003:119; 461-72 (Pubitemid 36588824)
56. Ma W, Behar T, Chang L, et al. Transient increase in expression of GAD65 and GAD67 mRNAs during postnatal development of rat spinal cord. J Comp Neurol 1994:346; 151-60 (Pubitemid 2118699)
57. Alvarez FJ, Jonas PC, Sapir T, et al. Postnatal phenotype and localization of spinal cord V1 derived interneurons. J Comp Neurol 2005:493; 177-92 (Pubitemid 41677476)
58. Rotshenker S, Reichert F, Gitik M, et al. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia 2008:56; 1607-13
59. Deng HX, Shi Y, Furukawa Y, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 2006:103; 7142-47
60. Prudencio M, Durazo A, Whitelegge JP, et al. An examination of wildtype SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet 2010:19; 4774-89
61. Stephens B, Navarrete R, Guiloff RJ. Ubiquitin immunoreactivity in presumed spinal interneurones in motor neurone disease. Neuropathol Appl Neurobiol 2001:27; 352-61 (Pubitemid 32990076)
62. Schutz B. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol Dis 2005:20; 131-40 (Pubitemid 41219210)
63. Vucic S, Cheah BC, Kiernan MC. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol 2009:220; 177-82
64. Attarian S, Pouget J, Schmied A. Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time. Muscle Nerve 2009:39; 310-17
65. Raynor EM, Shefner JM. Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology 1994:44; 2148-53 (Pubitemid 24349521)
66. Hegedus J, Putman CT, Tyreman N, et al. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 2008:586; 3337-51 (Pubitemid 352003870)
67. Pun S, Santos AF, Saxena S, et al. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006:9; 408-19 (Pubitemid 43290971)
68. Henkel JS, Beers DR, Zhao W, et al. Microglia in ALS: The good, the bad, and the resting. J Neuroimmune Pharmacol 2009:4; 389-98
69. Beers DR, Ho BK, Siklos L, et al. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem 2001:79; 499-509 (Pubitemid 33029923)
70. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010:6; 193-201
71. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009:64; 783-90
72. Chia R, Tattum MH, Jones S, et al. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One 2010:5; e10627
73. Xu YF, Gendron TF, Zhang YJ, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci 2010:30; 10851-59
74. Stallings NR, Puttaparthi K, Luther CM, et al. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis 2010:40; 404-14
75. Wils H, Kleinberger G, Janssens J, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2010:107; 3858-63
76. Wegorzewska I, Bell S, Cairns NJ, et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2009:106; 18809-14